Amazentis

Amazentis

Private
LausanneConsumer & Commercehttps://timeline.com

Last Round

Grant

May 19, 2025

Total Funding Raised

$87.36M

Momentum Score

25 /100

Company Overview

Amazentis is a biotechnology company that develops nutritional and skincare products to combat aging and improve quality of life.

Sector

Consumer & Commerce

Verticals

D2C Brands, Biotechnology, E-commerce, Subscription Commerce, Fashion & Beauty

Business Model

B2C

Customer Profile

Data as a Service, Subscription SaaS

AI Layer

Non-AI

Keywords

Urolithin AMitopuremitochondrial healthhealthy aginglongevity supplementsmitophagynutraceuticalscellular healthUrolithin A supplementsanti-aging supplementsclinically studied supplementsmuscle healthingredient licensingdirect-to-consumerbiohackingTimeline Nutritiontopical skincare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amazentis Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Amazentis Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 19, 2025
Series DJan 17, 2024
Series BSep 25, 2023
Series C ExtensionApr 2, 2019
Series CMar 21, 2018

Amazentis Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2025

    Secured $250K in grant funding.

  • May 12, 2025

    Recognized as a Top 40 global team for innovative approaches.

Amazentis Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amazentis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amazentis's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range74
Year Founded2007
Last FundingMay 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.